A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out the highest possible dose of maprotiline that
can be given safely in combination with temozolomide and tamoxifen.